高级检索
    邵亚蒙, 高新春, 陈磊, 陆远. 中性粒细胞/淋巴细胞对高龄急性心肌梗死患者新发心衰的预测价值[J]. 徐州医科大学学报, 2022, 42(6): 441-445. DOI: 10.3969/j.issn.2096-3882.2022.06.010
    引用本文: 邵亚蒙, 高新春, 陈磊, 陆远. 中性粒细胞/淋巴细胞对高龄急性心肌梗死患者新发心衰的预测价值[J]. 徐州医科大学学报, 2022, 42(6): 441-445. DOI: 10.3969/j.issn.2096-3882.2022.06.010
    Prognostic value of neutrophil/lymphocyte ratio in new-onset heart failure in elderly patients with acute myocardial infarction[J]. Journal of Xuzhou Medical University, 2022, 42(6): 441-445. DOI: 10.3969/j.issn.2096-3882.2022.06.010
    Citation: Prognostic value of neutrophil/lymphocyte ratio in new-onset heart failure in elderly patients with acute myocardial infarction[J]. Journal of Xuzhou Medical University, 2022, 42(6): 441-445. DOI: 10.3969/j.issn.2096-3882.2022.06.010

    中性粒细胞/淋巴细胞对高龄急性心肌梗死患者新发心衰的预测价值

    Prognostic value of neutrophil/lymphocyte ratio in new-onset heart failure in elderly patients with acute myocardial infarction

    • 摘要: 目的 探讨中性粒细胞/淋巴细胞比值(NLR)在高龄急性非ST段抬高型心肌梗死非血运重建治疗患者新发心力衰竭的预测价值。方法 回顾性收集164例高龄急性非ST段抬高型心肌梗死非血运重建患者病人基本信息、实验室检测结果等相关指标,观察入院后新发心力衰竭情况,根据有无新发心力衰竭情况,将其分两组,比较两组患者临床特征,采用Logistic回归分析影响新发心力衰竭发生的因素,ROC曲线进一步评估预测价值。结果 高龄急性非ST段抬高型心肌梗死非血运重建治疗患者新发心力衰竭发生率为53.66%;新发心力衰竭组NLR显著高于未发生组,多因素logistic回归分析NLR为高龄急性非ST段抬高型心肌梗死非血运重建治疗患者新发心力衰竭的独立危险因素(HR=1.158,95%CI?1.~1.290,P=0.0),ROC曲下面积0.(95% CI:0.~0.),P;最佳截断值敏感度%,特异性%。结论 NLR可以作为评价高龄急性非ST段抬高型心肌梗死非血运重建治疗患者新发心力衰竭的预测指标。

       

      Abstract: ob<x>jective To investigate the predictive value of neutrophil/lymphocyte ratio (NLR) in new-onset heart failure in elderly patients with acute non-ST-segment elevation myocardial infarction without revascularization therapy. Methods Retrospective collection of senile acute non-ST segment elevation myocardial infarction patients without reascularization patients’ basic information, laboratory test results and related indicators, such as cardiovascular adverse events will be whether the new heart failure is divided into two groups, compared two groups of clinical features, Logistic regression analysis the influence factors of new heart failure occurs, the ROC curve evaluation prediction value. Results The incidence of new heart failure in elderly patients with acute non-ST-segment elevation myocardial infarction without revascularization was 53.66%. Multivariate logistic regression analysis showed that NLR was an independent risk factor for new-onset heart failure in elderly patients with acute non-ST-segment elevation myocardial infarction without revascularization therapy(HR=1.158,95%CI?1.~1.290,P=0.0). The ROC curve area was 0.7 (95%CI: 0.706-0.855, P<0.01), the sensitivity was 71.2%, and the specificity was 76.2%. Conclusion NLR can be used as a predictor of new heart failure in elderly patients with acute non-ST-segment elevation myocardial infarction without revascularization therapy

       

    /

    返回文章
    返回